Subcategories
-
مقالات
- Article Count:
- 87
Researches of scientists of Oklahoma have revealed that fundamental cells, extracted from lipid tissue during liposuction process may be used for development of new blood vessels of low diameter, used in by-pass surgery and other processes accordingly.
Millions of patients, suffering from cardiovascular disorders do need grafting thin vessels for the processes, which do require return of blood to blocked vessels. The vessels obtained from liposuction, which are developed in laboratories, may help solve the main problems, associated with grafting of blood vessels from other parts of body or artificial vessels, which are not live tissues.
The said researches have changed fundamental cells, obtained from lipid to soft muscular cells at laboratory and then, they develop the said cells on a thin membrane of Collagen, which has been devised inside a tube as much as a tiny blood vessel.
Researchers hope that they would be able to test the said prefabricated samples of the said technology on animals in the next six months.
The said research has been presented in scientific conferences of basic sciences of cardiology of American Heart Association.
In a new achievement the American scientists have successfully manufactured a new manual system which injects a small ice bell under the skin and in this way it prevents from pain transmission in the patients suffering from arthritis.
The effect of this outpatient treatment which takes less then a few minutes is similar to local anesthetics; however, it has a longer effect.
Now the scientists have began a larger trial by using this method and have tested that on the patients suffering from knee arthritis.
When cartilages at the end of bones are destroyed as the result of abrasion, bones overlap and experience friction causing pain.
One out of each adult suffers from knee arthritis. Treatments for this pain encompass a range of steroid injections and calmatives to surgery and replacement of joints.
This system is called Cryo-Touch system and is a non-surgical approach which removes pharmaceutical need.
This icy treatment is a kind of Cryotherapy in which physicians use very cold temperatures to treat different diseases.
This treatment is used for different skin diseases including freezing of small skin cancers and benign tumors such as wart.
Cryotherapy is also used to treat prostate cancer in which physicians freeze cancer cells.
Researchers have recently used this method for the pain of joints especially in elbow, knee and shoulder.
This modern system that has been approved for use in UK is constituted of three stainless steel needles which are connected to a cylinder containing fluid nitrogen oxide.
These needles are designed to prevent from transmission of this very cold material into tissues which may cause serious injuries in case of contact.
Instead, when the fluid exits from the needle, it will change into gas due to very high pressure. This causes the needle to become very cold and an icy ball is produced on its top. In this system, three needles are used to increase the icy ball volume.
These needles are plunged within a few millimeters under the skin. Then, the system starts and a small icy ball is formed under the skin.
This icy ball damages to the blood vessels that transmit blood to the peripheral nerves around the joint. These nerves cannot send pain signs without any blood source.
Each treatment takes about 5 minutes. The physician lets the icy ball to become warm and then pulls out the needles.
A former human research conducted by the University of Washington with a similar technology showed that this treatment was effective for some patients and its effect remained for eight months.
The pain returns with the growth of new blood vessels and reactivation of nerves. In such case, another injection period may be effective.
Mr. Seyed Hosein Etemadi Monfared ,PhD,the founder of Yaghoot Rooyan Holding Group announced that the Ministry Of Health and Medical Sciences (MOH) issued the permission of principled agreement for constructing the pharmaceutical raw material manufacturing factory.
“ this permission is issued under the name of Sepid Teb Nia International Co. as one the subsets of Yaghoot Rooyan Holding group after the legal committee of assessment of Eligibility for production and import of drugs and Biologic Materials study and confirmation” Mr. Etemadi added while noting this issue.
He declared that the Supplements and Specific Foods of MOH has agreed with the pharmaceutical raw material import under the name of Nano Sepid Farmed Co. as another subsets of Yaghoot Rooyan Holding Group and added “these macro- projects based on this permission are aimed to promote the supply chain of pharmaceutical raw material and cooperate with internal and overseas industries and drug research centers emphasizing communication system with manufacturers.
Mr. Etemadi, PHD, also said that Hasti Daroo Darman international Co. as one of the Yaghoot Rooyan Holding Group also could obtain the principled agreement for establishment of co-laboratory in the field of Hygienics and cosmetics, food supplements, and specialized laboratories for hair color from technical committee of assessment and approval of allowed laboratories inside the country. So this company can observe the realization of new processes according to the last research and scientific achievements from now on.
The Yaghoot Rooyan Holding Group founder also expressed at the final part of his press conference “one of the most outstanding achievements of this Holding is obtain the permission for production of some food supplements such as Beta caroten, B12, L-citrolin,L-Ajenine and many other kinds of drugs under the name of Sepid Teb Nia International Co. from Ministry Of Health and Medical Sciences and also the permission for production special establishment, designing and assembling some of the Hygienic and cosmetic products under the name of Asal Daroo Kish International Co. from the ministry of industry, mine and commerce . we proud of all these achievements.”
An anti-cancer medicine of “Taxotere”, has been produced at laboratory quantities, thanks to unsparing efforts of researchers and professors of Research Institute of Medicinal Raw Materials and Herbals of Shahid Beheshti University.
As reported by scientific service of ISNA, Docetaxel under the name of “Taxotere”, is one of the mostly consumed and the most expensive medicines of high frequency, used for control and treatment of such cancers as ovaries, prostates, breast, lungs and the ones.
Presently, over 6 kilograms of the said medicine, equivalent of 50,000,000.- Dollars is used in Iran. The said medicine is exclusively produced by a limited number of countries.
“Docetaxel is a semi-synthetic D amide, similar to Paklitaxel (a similar medicine), which is synthesized from a precursor material, derived from the leaves of Taxus Bacca tree.
Presently, all production stages of the said medicine including synthesis and purification are done at laboratory quantity at Research Institute of Medicinal Raw Materials and Herbals of Shahid Beheshti University and it is possible to present the said medicine to pharmaceutical industry accordingly.
Benefiting from kind assistance of a group of top specialists of the country in organic medicines, Sepid Teb Nia Pharmaceutical Research and Development Company has celebrated honorable commencement of its activity in Sept of this year. In the said eve, Dr Seyed Jafar Mir Fakhraee, Secretary of Syndicates for Manufacturers of Herbal Medicines stated that accomplishment of various projects in the country in the areas of pharmaceutical engineering, molecular biology and formulation promises ever-increasing promotion of scientific level and realization of divine goals of health in the society and the most significant reliance of practitioners in the said area is to obtain the most important and effective achievements in the said industry. Moreover, Ms Dr Pour Shaghaghi, Managing Director of Sepid Teb Nia Company stated on scientific characteristics of the said center and further added: Thanks to valuable knowledge and scientific learning of its colleagues, Sepid Teb Nia Company has the capability to exchange technologies for producing herbal medicines and supplements at global quality standard levels through active and well-known producers all over the world (especially European producers) to our beloved homeland, Iran, the said Company may act upon development of new formulations, innovation in taking the best advantages of fresh compounds and materials, and eventually producing distinguished products in the Middle East.
Moreover, Dr Seyed Hossein Etemadi, the founder of Yaghout Rooyan Corporation, stated that he was grateful with accomplishment of the aforesaid project. He further added that being pioneer in presenting essential approaches with respect to public health promotion shall be an honor for this Company because we all do believe that the most significant concern of each Iranian individual is to serve his beloved homeland and to Iranians. He pointed out that materialization of research projects in the said field, modification of pharmaceutical problems of people of different classes, optimization of safety-pharmaceutical standards in the nation and reengineering of production procedures in the said area all designate growingly jump of the said industry. In conclusion, he stated his hopefulness for registration of new medicines, manufactured by the said Company in near future with scientific circles and distribution of the same in global production markets accordingly. He also pleaded with Almighty God for ever-increasing success of health practitioners across the nation.
Yaghoot Rooyan International Group was founded in 1991 aiming to import food supplements, pharmaceuticals, medical equipments and also herbal hygienic and cosmetic products for caring and protecting of public health and hair and skin beauty. This group has supplied the market with unique products under different commercial brands to satisfy the society requirements by its exclusive agency from more than 21 Stated manufacturers in Europe and U.S.A and now is moving forward with the precious aim of transmitting the manufacturing technology to Iran and reaching national independence. The food supplements and hygienic and cosmetic products of Yaghoot Rooyan International Group are confirmed by the expert Physicians and scientific sessions in internal international area supporting by its superior quality and performance.
Presenting different scientific articles and close co operations with experts and scholars inside and outside the country is some of the Yaghoot Rooyan International Group’s achievement’s to support researchers and promote the activities. The exterritorial activities of this group are also significant and increasing.
Chronic venous insufficiency is the main cause of Varicose Veins disease. While chronic venous insufficiency (CVI) is the most prevalent cause for leg pain and its inflation, this insufficiency occurs when venous valves lack the required performance and blood circulation in leg is impaired.
20% of adults suffer from this disease and on this basis the number of women is higher than men.
In this new treatment method, the disabled value is replaced with an efficient implant.
At the present time, this implant is not prepared to be used in the patients' bodies and it is in the trial phase.
In case this implant is put into practice, most vascular diseases can be treated through this method.
It should be mentioned that Erbaven Retard is one of the highly popular products of Yaghout Company. Besides causing positive effects in those patients suffering from varicose veins, this product has also been effective in the re-health of feet.
Feedbacks:{jcomments on}
Mr. Seyed Hosein Etemadi Monfared ,PhD,the founder of Yaghoot Rooyan Holding Group announced that the Ministry Of Health and Medical Sciences (MOH) issued the permission of principled agreement for constructing the pharmaceutical raw material manufacturing factory.
“ this permission is issued under the name of Sepid Teb Nia International Co. as one the subsets of Yaghoot Rooyan Holding group after the legal committee of assessment of Eligibility for production and import of drugs and Biologic Materials study and confirmation” Mr. Etemadi added while noting this issue.
He declared that the Supplements and Specific Foods of MOH has agreed with the pharmaceutical raw material import under the name of Nano Sepid Farmed Co. as another subsets of Yaghoot Rooyan Holding Group and added “these macro- projects based on this permission are aimed to promote the supply chain of pharmaceutical raw material and cooperate with internal and overseas industries and drug research centers emphasizing communication system with manufacturers.
Mr. Etemadi, PHD, also said that Hasti Daroo Darman international Co. as one of the Yaghoot Rooyan Holding Group also could obtain the principled agreement for establishment of co-laboratory in the field of Hygienics and cosmetics, food supplements, and specialized laboratories for hair color from technical committee of assessment and approval of allowed laboratories inside the country. So this company can observe the realization of new processes according to the last research and scientific achievements from now on.
The Yaghoot Rooyan Holding Group founder also expressed at the final part of his press conference “one of the most outstanding achievements of this Holding is obtain the permission for production of some food supplements such as Beta caroten, B12, L-citrolin,L-Ajenine and many other kinds of drugs under the name of Sepid Teb Nia International Co. from Ministry Of Health and Medical Sciences and also the permission for production special establishment, designing and assembling some of the Hygienic and cosmetic products under the name of Asal Daroo Kish International Co. from the ministry of industry, mine and commerce . we proud of all these achievements.”